Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 20:20:74-79.
doi: 10.1016/j.amsu.2017.06.027. eCollection 2017 Aug.

Porocarcinoma; presentation and management, a meta-analysis of 453 cases

Abdulwahid M Salih  1 , F H Kakamad  2   3 , Hiwa O Baba  4 , Rawezh Q Salih  3   5 , M R Hawbash  3   6 , Shvan H Mohammed  3   5 , Snur Othman  4 , Yadgar A Saeed  4 , Imad J Habibullah  4 , Aso S Muhialdeen  4 , Rebaz O Nawroly  4 , Zuhair D Hammood  4 , Nawshirwan H Abdulkarim  4
Affiliations
Review

Porocarcinoma; presentation and management, a meta-analysis of 453 cases

Abdulwahid M Salih et al. Ann Med Surg (Lond). .

Abstract

Background: porocarcinoma is a rare sort of skin cancer developing from sweat glands. Its clinical course and management are not well understood.

Objectives: the current meta-analysis is to address the presentation and management of porocarcinoma.

Data sources: Web of Science, PubMed, MEDLINE on OVID and Google scholar were searched for English-language studies published before December 1, 2016.

Results: The review of literature revealed 453 cases. From which 222 (49%) cases were male and female were 231 (51%). The mean age was 67.57 years. The mean duration of presentation was 5.57 years ranging from 4 days to 60 years of age. The most common site of affection is the head and neck (39.9%) followed by lower extremity (33.9%). Mass and nodule are the most common modes of presentation. Metastasis occurred at presentation in 110 (31%) cases. The most common organ to which porocarcinoma metastizes is the nearby lymph node (57.7%).

Conclusions: Porocarcinoma is an aggressive skin cancer. Surgery is the main modality of treatment.

Systematic review registration number: reviewregistry233.

Keywords: Aggressive; Carcinoma; Management; Porocarcinoma; Presentation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The process and flow of the literature review.
See this image and copyright information in PMC

References

    1. Devi N.R., Valarmathi K., Lilly M., Satish S., Mishra N. Primary axillary porocarcinoma: a rare cutaneous tumour. J. Clin. Diagn. Res. 2016;10(2):4–6. - PMC - PubMed
    1. Luz Murilo de Almedia, Ogata Daniel Cury, Ribeiro Leandro Carvalho. Eccrine porocarcinoma (malignant Eccrine poroma) Clin. (Sao Paulo) 2010;65(7):739–742. - PMC - PubMed
    1. Zeidan Youssef H., Jason Zauls A., Sharma Anand K. Treatment of Eccrine porocarcinoma with metastasis to parotid gland. J. Med. Case Rep. 2010;4:147. - PMC - PubMed
    1. Fujimura Taku, Hashimoto Akira, Aiba Setsuya. Succesful treatment of eccrine porocarcinoma. Case Rep. Dermatol. 2014;6(2):159–163. - PMC - PubMed
    1. Smita Surendra Masamatti, Chowdappa Vijaya. Eccrine porocarcinoma of scalp. J. Clin. Diagn. Res. Ser. online) 2016;1(1):1–16. - PMC - PubMed

Further reading

    1. Yamamoto Osamu, Haratake Joji, Yokoyama Shigeo, Imayama Shuhei, Asahi Masakazu. A histopathological and ultrastructural study of eccrine porocarcinoma with special reference to its subtypes. Virchows Arch. A Pathol. Anat. 1992;420:395–401. - PubMed